coliform strains causing symptomatic and asymptomatic bacteriuria.
Summary
The bacteriological consequences of giving long-term low-dose co-trimoxazole to children to prevent reinfection of the urinary tract were studied. Only six "breakthrough" infections occurred during 2637 child-months of prophylaxis. The children complied well with treatment. During prophylaxis the number of rectal coliform bacilli recovered was greatly and rapidly reduced, but at least 700' of the surviving coliform organisms remained sensitive to the two components of co-trimoxazole. Changes in sensitivity pattern were evident within a month of starting treatment and the proportion of rectal organisms resistant to sulphonamide or trimethoprim did not increase with time.
After stopping co-trimoxazole prophylaxis the number of rectal organisms recoverable returned rapidly to normal, as did their sensitivities to trimethoprim and sulphonamide. Further episodes of urinary tract infection developing after prophylaxis was stopped were caused by organisms sensitive to a wide range of antimicrobial agents, including trimethoprim. flora is the source from which new organisms causing urinary tract infection are derived, a good prophylactic drug should not generate a resistant rectal flora and should also be active against a high proportion of potential urinary pathogens, thereby maintaining a sterile urine.
Nitrofurantoin is an effective prophylactic drug,1 2 and we have shown that it does not generate a resistant bowel flora, whereas sulphonamide and ampicillin are less satisfactory. 2 We have shown (see part I) that continued low-dose cotrimoxazole is also very effective in preventing reinfection during treatment. This paper reports the bacteriological effects on the urine and bowel flora of long-term low-dose co-trimoxazole, which is a mixture in fixed proportions of trimethoprim (TMP) and sulphamethoxazole (SMX).
Patients and methods
One hundred and thirty children aged 1-12 were studied. They each received at least six months' prophylactic treatment with cotrimoxazole in a dose of 2 mg TMP and 10 mg SMSX/kg/day.
Urine samples and rectal swabs were collected immediately before starting prophylaxis, at two, four, and eight weeks and then every three months during treatment and at the same intervals after stopping treatment. The methods of sample collection and the duration of treatment and follow-up have already been described (see Part I).
All rectal swabs were plated on to two plates of MacConkey's agar to give separate colonies, and the plates were then incubated overnight. With this method rectal swabs generally yield many coliforms, but early in this study it was noted that the growth of coliforms was often scanty or absent. This was attributed to faulty sampling until it became apparent that this was an effect of co-trimoxazole treatment. Whenever possible 10 colonies of coliform organisms were picked off, purified, tested for sensitivity to antimicrobial agents and identified. When several colonial types were present they were sampled in proportion to their frequency.
Results

COMPLIANCE
During prophylactic treatment with low-dose co-trimoxazole examination of random urine samples showed that 930,1, of children were taking their prescribed treatment.
RECTAL FLORA
Two or more satisfactory rectal swabs were collected from 100 children (13 boys, 87 girls) and a total of 713 rectal swabs were examined. If an infection developed during or after prophylaxis with co-trimoxazole that required treatment with a different antibacterial drug further immediate serial observations on the child were excluded. Swabs taken during 12 further courses of prophylactic co-trimoxazole given after eradication of a reinfection were studied and included.
Effect of co-trinmoxazole oni ntlimbers of organisms isolated Rectal swabs were collected from 76 children before starting prophylactic treatment, and all but two of these yielded a heavy growth of coliform bacilli ( This reduction in numbers of coliform organisms did not occur uniformly among the children treated. Although in 34 children culture of serial rectal swabs yielded no coliform bacilli throughout treatment, rectal swabs from 13 children known to be taking their treatment consistently yielded 10 or more enterobacteria per swab culture, while in 53 children the numbers of organisms yielded by culturing repeated rectal swabs fluctuated from none to over 10, an effect that was not related to failure to take the drug.
The reduction in the number of coliform bacilli recoverable from rectal swabs collected from the treated children was short-lived after co-trimoxazole was withdrawn, as shown in table II. At the time of stopping prophylaxis 17 (41 o.) out of 41 rectal swabs examined yielded fewer than 10, or no, colonies of coliform bacilli whereas one month later only one out of 21 rectal swabs yielded less than 10 colonies. Thereafter, normal numbers of enterobacteria were recoverable. The rapid return of many faecal coliform bacilli occurred irrespective of the duration of prophylaxis. These changes in bowel flora sensitivity were short-lived after treatment was withdrawn (table V) . At the time of stopping co-trimoxazole prophylaxis 89 60o of the rectal coliform flora grown were sensitive to TMP and 69100 were sensitive to sulphonamides. Within a month 9900 were sensitive to TMP once more, and the proportioni of organisms sensitive to sulphonamides had risen to 7500.
TMP-resistant organisms
Four hundred and twenty-six TMP-resistant organisms were isolated from 56 rectal swabs collected from 37 children during prophylaxis. During the first year of co-trimoxazole prophylaxis 232 TMPresistant organisms were isolated: 128 Acinetobacter spp, 67 Escherichia coli, 4 Citrobacter freundii, 4 Enterobacter hafniae, 10 Klebsiella spp, 11 Proteus spp, and 8 Pseudomonas spp. A further 194 TMPresistant organisms were isolated from rectal swabs taken from children who had had prophylaxis for over a year: 25 Acinetobacter spp, 149 Esch coli, 10 Enterobacter cloacae, and 10 Klebsiella spp. The commonest rectal TMP-resistant "coliform" organism after short periods of exposure to TMP seemed to be Acinetobacter spp, whereas the commonest organism after longer periods was Esch coli. Examination of further swabs during prophylaxis from children in whom a rectal swab culture had already yielded a TMP-resistant organism was possible in 43 cases. The next culture yielded no coliform organisms in 17, all 10 organisms fully sensitive to TMP in 12, and further TMP-resistant isolations in only 14. In other words, the rectal carriage of TMP-resistant organisms in these children was usually only transient.
FURTHER URINARY TRACT INFECTIONS
During prophylaxis with co-trimoxazole Only six children developed urinary infection during prophylactic co-trimoxazole treatment. In all cases these were reinfections with organisms resistant to sulphonamide and TMP but sensitive to other drugs, and they were rapidly eradicated with treatment.
After withdrawal of co-trimoxazole
After cessation of co-trimoxazole prophylaxis 4300 of the 63 children studied developed new episodes of urinary tract infection. These were episodes of reinfection with new organisms which were nearly always predominant in the rectal flora. In these reinfections the children were usually symptomless. Had (table II) and also return to their normal levels of TMP-resistance (table  V) 
